¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
10/15 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2022-10-12
Á¶È¸¼ö
200


¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù.

Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2021³â Cell reports ¿¡ ÃâÆǵÈ
"
A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge" ÀÔ´Ï´Ù.

º» ³í¹®¿¡¼­´Â SARS-CoV-2 ÀÇ N protein °ú full S protein ¿¡ flagellin, cyclic GMP-AMP ¸¦ ÇÕÃÄ Èĺ¸ ¹é½ÅÀ» ¸¸µé¾ú°í ÀÌ Èĺ¸ ¹é½ÅÀÌ systemic, mucosal humoral immunity ¸¦ °­ÇÏ°Ô ÀÏÀ¸Å°´Â °ÍÀ» È®ÀÎÇß½À´Ï´Ù. ¶ÇÇÑ ÀÌ ¹°ÁúÀº intranasal route ¸¦ ÀÌ¿ëÇÏ¿© È£Èí±â°ü¿¡ ¸é¿ª¹ÝÀÀÀ» Çâ»ó½ÃÄ×À¸¸ç human ACE2 transgenic mice ¿¡¼­µµ º¸È£È¿°ú¸¦ ³ªÅ¸³»´Â °ÍÀ» È®ÀÎÇÏ¿´½À´Ï´Ù.

SARS-CoV-2 ¹é½Å, adjuvant °ü·Ã Èĺ¸¹°Áú¿¡ ´ëÇÑ ½ÇÇèµðÀÚÀÎÀ» °øºÎÇغ¸°íÀÚ ¼±Á¤Çß½À´Ï´Ù. 

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.

³í¹®»çÀÌÆ®:
A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge - ScienceDirect
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
10/15 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä ¹Î¼ºÀÔ´Ï´Ù. Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº 2020³â Science ImmunologyÀú³Î¿¡ °ÔÀçµÈ"Shiga toxin suppresses noncanonical inflammasome responses to cytosolic LPS"ÀÔ´Ï´Ù. TLRÀ» ÅëÇÑ LPSÀÇ ÀνÄÀº caspase-1 activatioÀ» À¯µµÇϸç ÀÌ´Â IL-1b¿Í °°Àº ¹°ÁúÀ» ºÐºñÇÏ´Â canonical inflamma..
ÀÌÀü±Û
10/8 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
À̹ø ÁÖ ¹ßÇ¥ÀÚ µµºóÀÔ´Ï´Ù. À̹ø ¹ßÇ¥ ³í¹®Àº ¿ÃÇØ 2¿ù Immunity ¿¡ ÃâÆÇµÈ 'Primary germinal center-resident T follicular helper cells are a physiologically distinct subset of CXCR5hiPD-1hi T follicular helper cells'ÀÔ´Ï´Ù. Follicular helper T cell (Tfh) Àº germinal center ¿¡¼­ affinity..